M

Mendaera

Delivers point-of-care medical devices

Engineering Manager - Web Platform and Infrastructure

Full-Time
$179k - $190.5k/yr
Mid, Senior
Bachelor's
San Mateo, CA, USA
In Person
Engineering ManagementEngineering Leadership

About the job

Requirements
  • A Bachelor's degree in Computer Science, Engineering, or a related field, or equivalent experience.
  • At least 5 years of experience in infrastructure or DevOps, including at least 2 years in a leadership or management role.
  • Strong technical background in Amazon Web Services, networking, and infrastructure-as-code.
  • Experience with web application infrastructure and internal tools.
  • Hands-on experience with observability tooling, including Prometheus, Splunk, and CloudWatch.
  • Technical communication skills and the ability to influence cross-functionally.
  • A track record of building and leading high-performing engineering teams.
Responsibilities
  • Lead and mentor a team of engineers across infrastructure, compliance, and internal web platforms while contributing as an individual contributor on core projects.
  • Define and drive the technical vision for infrastructure and internal systems, balancing leadership with hands-on implementation.
  • Establish consistency in infrastructure-as-code using Terraform across Amazon Web Services environments.
  • Oversee compliance practices for frameworks such as SOC 2, HIPAA, and medical device regulatory requirements.
  • Lead development of Mendaera's internal web portal to support manufacturing, service, and other operational workflows.
  • Partner with stakeholders across engineering, clinical, and regulatory teams to align on priorities and execution.
  • Enforce and maintain high standards for security, observability, automation, and availability.
Desired Qualifications
  • Experience supporting medical device systems or other regulated environments.
  • Familiarity with compliance frameworks including SOC 2, HIPAA, and HITRUST, and regulated software development.
  • Background in security architecture design and evaluation.
  • Proficiency with Linux systems administration and troubleshooting.

About the company

Mendaera provides medical devices and healthcare technology designed to support clinicians at the point of care. Its solutions help doctors and nurses perform procedures with higher precision and consistency directly where patients receive treatment, aiming to streamline care and improve outcomes. The devices integrate into the care workflow to reduce unnecessary patient movement, speed recovery, and lower overall costs. Revenue comes from selling these technologies to hospitals, clinics, and individual practitioners, with engagement also involving administrators and payors to align value and reimbursement. The company adheres to regulatory standards to ensure safety and effectiveness, partnering with regulators and stakeholders to bring compliant technologies to market. Overall, Mendaera’s goal is to improve patient outcomes, boost patient satisfaction, and reduce the cost of care by making medical interventions more efficient at the point of care.

Company Size

51-200

Company Stage

Series B

Total Funding

$97M

Headquarters

San Mateo, California

Founded

2020

Get referred to Mendaera

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 12, 2026 study reported 60 of 61 procedures succeeded, with zero adverse events.
  • Threshold Ventures led Mendaera's $73 million Series B, funding commercialization and expansion.
  • October 2026 ACEP visibility with Butterfly expands clinician awareness across emergency medicine.

What critics are saying

  • Early commercialization in 2026 means revenue remains unproven beyond pilot deployments.
  • Butterfly and ultrasound vendors can dictate integration terms, squeezing Mendaera's margins.
  • If Focalist adoption stalls, Mendaera becomes an expensive single-product robotics platform.

What makes Mendaera unique

  • Focalist pairs handheld robotics, real-time imaging, and guidance software for needle procedures.
  • On October 1, 2026, Butterfly compatibility made Mendaera's first partner commercial launch.
  • FDA clearance in July 2025 gives Mendaera regulatory credibility versus unapproved robotics startups.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget

Growth & Insights and Company News

6 month growth

1%

1 year growth

2%

2 year growth

1%
Start LLC
Oct 2nd, 2026
Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe.

Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe. Mendaera announced its handheld robot for needle-based procedures is now available to pair with Butterfly Network's (NYSE:BFLY) portable, chip-based ultrasound probe, following the companies' long-running collaboration. The Focalist robotic image-guided system assists clinicians in aiming to place IV lines, deliver nerve blocks or otherwise access organs and vasculature without additional specialized training. After FDA clearance in July 2025, its first procedures included removing kidney stones through minimally invasive nephrolithotomy. Mendaera signed up as the first partner in the Butterfly Embedded technology licensing program, shortly after the developer's debut in 2023, with a commercialization deal that included sharing the revenue of every combined unit sold.

Yahoo Finance
Oct 1st, 2026
Mendaera's Focalist™ system launches with Butterfly's Ultrasound-on-Chip™ technology

Mendaera has launched a version of its Focalist system compatible with Butterfly Network's Ultrasound-on-Chip technology. This marks the first Butterfly Embedded partner technology to reach the market. Mendaera's FDA-cleared Focalist system combines handheld robotics, real-time imaging, and intelligent guidance software for image-guided needle procedures, including vascular access, regional nerve blocks, and organ access. The collaboration brings together imaging and robotics technologies with the aim of advancing digitally native, AI-enabled intervention. Butterfly's software-defined architecture enables a path towards AI-enabled image interpretation and robotic action. Mendaera and Butterfly will both exhibit at the American College of Emergency Physicians Scientific Assembly on 5-7 October 2026 in Chicago, Illinois.

Archyde
Jul 8th, 2025
Mendaera Secures $73M to Revolutionize Robotics

Mendaera, a healthcare robotics firm, secured $73 million in Series B funding, following a $24 million Series A led by Lux Capital in 2023. The funds will help scale their robotic and AI technologies for medical procedures like biopsies and organ access. Mendaera is expanding partnerships, including with Cook Medical and EchoNous, to enhance needle-based interventions. They also acquired Avail Medsystems' telepresence tech to improve patient access and care delivery.

Bioscience Association Manitoba
Apr 28th, 2025
Cook Medical collaborates with Mendaera(TM) to advance needle-based intervention with handheld robotics

Cook Medical collaborates with Mendaera(TM) to advance needle-based intervention with handheld robotics.

BioSpace
Jan 9th, 2025
Mendaera Appoints Medical Robotics Leader Eric Davidson as Chief Commercial Officer

Mendaera appoints medical robotics leader Eric Davidson as Chief Commercial Officer.